EGEdmo Atique Gabriel

Edmo Atique Gabriel

*This is an algorithmically generated author record based on publicly available information.

Edmo Atique Gabriel has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Copper, Zinc, and Selenium Levels During Pregnancy and Their Relationship with Pre-Eclampsia Risk: A Systematic Review

    by Pietra dos Santos Goularte, Carlos Henrique Lima Imperador, Felipe Hassan Piedade, Amanda Nascimento Guerin, Karina de Toledo Martins, Diogo Boreski, Edmo Atique Gabriel, Sthefano Atique Gabriel, Daniel Guimarães Tiezzi, Chung Man Chin

    Pre-eclampsia (PE) affects about 5% of all pregnancies worldwide and is one of the leading causes of maternal and fetal morbidity and mortality. Some reports suggest that micronutrients may influence this condition, but there is no existing report analyzing data on copper (Cu), selenium (Se), and zinc (Zn) regarding quality and bias. Accurate information is crucial to support governmental healthcare actions, especially in developing countries such as Brazil. This study aims to investigate whether alterations in Zn, Cu, and Se levels in pregnant women contribute to the development of PE. We conducted the study following PRISMA guidelines and registered it on PROSPERO (CRD42022302298). We searched LILACS, PubMed/MEDLINE, EMBASE, and the Cochrane Library databases from January 2000 to January 2024. Of 1202 reports, 42 manuscripts were suitable for analysis (contained one or more micronutrients). A total of 76 individual analyses (by nutrient) were performed using Joanna Briggs Critical Appraisal and Cochrane Risk of Bias Tools. The analyses classified 69 reports as fair/low-quality with bias. Due to this, a meta-analysis was not conducted, as the results would not have accurately reflected reality. Of the high-quality reports, five on Cu showed conflicting results, while two studies on Zn found no differences in the level of this micronutrient between normal and PE pregnancies. No high-quality studies were identified for Se. The results highlight the need for robust guidelines for research involving micronutrients and PE to address this question effectively.


  • Open Access

    Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model

    by Daniela Hartmann Jornada, Diogo Boreski, Diego Eidy Chiba, Denise Ligeiro, Marcus Alexandre Mendes Luz, Edmo Atique Gabriel, Cauê Benito Scarim, Cleverton Roberto de Andrade, Chung Man Chin

    Colorectal cancer (CRC) is one of the top 10 most common cancers worldwide and caused approximately 10 million deaths in 2022. CRC mortality has increased by 10% since 2020 and 52.000 deaths will occur in 2024, highlighting the limitations of current treatments due to ineffectiveness, toxicity, or non-adherence. The widely used chemotherapeutic agent, 5-fluorouracil (5-FU), is associated with several adverse effects, including renal, cardiac, and hepatic toxicity; mucositis; and resistance. Taurine (TAU), an essential β-amino acid with potent antioxidant, antimutagenic, and anti-inflammatory properties, has demonstrated protective effects against tissue toxicity from chemotherapeutic agents like doxorubicin and cisplatin. Taurine deficiency is linked to aging and cancers such as breast and colon cancer. This study hypothesized that TAU may mitigate the adverse effects of 5-fluorouracil (5-FU). Carcinogenesis was chemically induced in rats using 1,2-dimethylhydrazine (DMH). Following five months of cancer progression, taurine (100 mg/kg) was administered orally for 8 days, and colon tissues were analyzed. The results showed 80% of adenocarcinoma (AC) in DMH-induced control animals. Notably, the efficacy of 5-FU showed 70% AC and TAU 50% while, in the 5-FU + TAU group, no adenocarcinoma was observed. No differences were observed in the inflammatory infiltrate or the expression of genes such as K-ras, p53, and Ki-67 among the cancer-induced groups whereas APC/β-catenin expression was increased in the 5FU + TAU-treated group. The mitotic index and dysplasia were increased in the induced 5-FU group and when associated with TAU, the levels returned to normal. These data suggest that 5-FU exhibits a synergic anticancer effect when combined with taurine.


  • Open Access

    Taurine Neuroprotection and Neurogenesis Effect in Chronic Ethanol-Induced Rats

    by Patricia Rodella, Diogo Boreski, Marcus Alexandre Mendes Luz, Edmo Atique Gabriel, Luiz Fernando Takase, Chung Man Chin

    Taurine (2-aminoethanesulfonic acid) is a non-protein β-amino acid essential for cellular homeostasis, with antioxidant, anti-inflammatory, and cytoprotective properties that are crucial for life maintenance. This study aimed to evaluate the effects of taurine administration on hippocampal neurogenesis, neuronal preservation, or reverse damage in rats exposed to forced ethanol consumption in an animal model. Wistar rats were treated with ethanol (EtOH) for a 28-day period (5% in the 1st week, 10% in the 2nd week, and 20% in the 3rd and 4th weeks). Two taurine treatment protocols (300 mg/kg i.p.) were implemented: one during ethanol consumption to analyze neuroprotection, and another after ethanol consumption to assess the reversal of ethanol-induced damage. Overall, the results demonstrated that taurine treatment was effective in protecting against deficits induced by ethanol consumption in the dentate gyrus. The EtOH+TAU group showed a significant increase in cell proliferation (145.8%) and cell survival (54.0%) compared to the EtOH+Sal group. The results also indicated similar effects regarding the reversal of ethanol-induced damage 28 days after the cessation of ethanol consumption. The EtOH+TAU group exhibited a significant increase (41.3%) in the number of DCX-immunoreactive cells compared to the EtOH+Sal group. However, this amino acid did not induce neurogenesis in the tissues of healthy rats, implying that its activity may be contingent upon post-injury stimuli.


  • Open Access

    Taurine Neuroprotection and Neurogenesis Effect in Chronic Ethanol Induced Rats

    by Patricia Rodella, Diogo Boreski, Luiz Fernando Takase, Edmo Atique Gabriel, Marcus Alexandre Mendes Luz, Chung Man Chin

    The ingestion of ethanol presents a significant global public health challenge. Chronic alcohol consumption is associated with the development of conditions such as cancer, cirrhosis, hepatic diseases, cardiovascular diseases, and diabetes, as well as neurological impairments that may predispose individuals to dementia, schizophrenia, and behavioral disorders such as violence and suicide. Alcohol-related fatalities constitute 5.3% of worldwide deaths annually, totaling approximately 3 million. Notably, alcohol consumption is implicated in 25% of cirrhosis-related deaths and 4.1% of cancer-related deaths. Taurine (2-aminoethanesulfonic acid) is a non-protein β-amino acid essential for cellular homeostasis, possessing antioxidant, anti-inflammatory, and cytoprotective properties crucial for life maintenance. This study aimed to evaluate the effects of taurine administration on hippocampal neurogenesis, neuronal preservation or reverse damage in rats exposed to forced ethanol consumption. Results demonstrated the neuroprotective effects of taurine on ethanol-treated rats, promoting tissue regeneration and suggesting its pivotal role in this process. However, this aminoacid failed to induce neurogenesis in the tissues of healthy rats, implying that its activity may be contingent upon post-injury stimuli.


  • Open Access

    Use of Antioxidants in Cardiovascular Surgery

    by Edmo Atique Gabriel, Camila Alcalde Mazza, Marina Mello

    Morbidity and mortality due to postoperative complications, related to inflammation and systemic oxidative stress, of coronary artery bypass grafting is high and inadmissible. It is suggested that numerous adverse outcomes may be caused by the systemic effect of cardiopulmonary bypass (CPB). One of the most damaging consequences of these events is the formation of reactive oxygen species (ROS) and radicals, which originate from a variety of cellular and enzymatic sources, such as myocardial cells, activated neutrophils, or endothelial xanthine oxidase. Many studies have described the nature of these ROS and the time of their formation during CPB. With the goal of reducing these damages, studies have investigated the use of antioxidant supplements during CPB. The present study focused on the time course of the innate antioxidant activity (antioxidant enzymes and overall antioxidant capacity in plasma) in patients undergoing CABG. The methodology used was the literature review.


  • Pathophysiology of Lesions in Coronary Bypass

    by Edmo Atique Gabriel, Letícia Oliveira

  • Inflammatory Response in Open and Endovascular Treatment

    by Edmo Atique Gabriel, Sthefano Atique Gabriel

  • Lung Protection in Cardiovascular Surgery

    by Edmo Atique Gabriel, Sthefano Atique Gabriel

  • Thyroid Hormones and Cardiovascular Surgery

    by Edmo Atique Gabriel, Sthefano Atique Gabriel